Avi Kulkarni is an experienced life sciences executive based in Silicon Valley. With over 30 years of experience in the industry, he has focused his career on capabilities-led transformations of life sciences companies, particularly in the areas of drug and diagnostics product development, mergers and acquisitions, and business commercialization processes.

Kulkarni obtained his bachelor's in pharmacy from the University of Bombay, followed by a PhD and MS in pharmaceutics from Temple University. He then went on to earn his MBA from Stanford's Graduate School of Business.

Throughout his career, Kulkarni has held various leadership positions in well-known companies such as Accenture, KPMG, QuintilesIMS (now IQVIA), and Booz & Company. He has also contributed his expertise to several startups, including CareDx/XDx, Lumen Therapeutics, and Aviir.

Kulkarni is recognized for his ability to integrate four key areas into his leadership view: strategy, operational performance, entrepreneurship, and scientific experience and scholarship. He is a seasoned professional with a strong technical background in diagnostics and drug development, making him an expert in functional areas such as business development, research and development, and commercial operations.

Overall, Avi Kulkarni's extensive experience, advanced education, and proven track record in both established firms and startups make him an important presence in the life sciences industry.